| Income Statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | |
|---|---|---|---|---|
| Total revenue | - | - | 134,270* | |
| Cost of revenue | - | - | 36,822* | |
| Gross profit | - | - | 97,448* | |
| Sales and marketing | 1,458,470 | 281,903 | 955,127.25* | |
| Research and development | - | - | 1,226,447.75* | |
| Research and development | 294,572 | 59,300 | 13,693.75* | |
| In-process research and development | 4,258,449 | - | - | |
| General and administrative | 3,877,442 | 2,121,840 | 1,276,883.75* | |
| Impairment of intangible asset | - | - | 660,070* | |
| Total operating expenses | 9,888,933 | 2,463,043 | 4,132,222.5* | |
| Loss from operations | -9,888,933 | -2,463,043 | -4,034,774.5* | |
| Other income | 19,905 | 14,540 | 10,545* | |
| Government grant | - | - | 133,375.75* | |
| Change in fair value of convertible debt | - | - | -5,250* | |
| Gain (loss) on sales and disposal of assets | - | - | -40,812* | |
| Interest expense | 7,208 | 15,175 | 93,364.5* | |
| Other expense | 196,084 | 21,917 | 32,899.25* | |
| Total other expense | -183,387 | -22,552 | -17,905* | |
| Loss before income tax | -10,072,320 | -2,485,595 | -4,052,679.5 | |
| Loss from continuing operations | -10,072,320 | -2,485,595 | - | |
| Loss from discontinued operations | -944,160 | -2,596,387 | - | |
| Net loss | -11,016,480 | -5,081,982 | -4,052,679.5* | |
| Foreign currency translation adjustment | -30,683 | -35,096 | -17,255.75* | |
| Reclassification of translation adjustment related to liquidation of foreign subsidiary | -683,433 | - | - | |
| Total comprehensive loss | -10,363,730 | -5,117,078 | -4,069,935.25 | |
| Basic EPS | -0.62 | -0.43 | -0.679 | |
| Diluted EPS | -0.62 | -0.43 | -0.679 | |
| Basic Average Shares | 17,851,499 | 11,799,424 | 5,996,887 | |
| Diluted Average Shares | 17,851,499 | 11,799,424 | 5,996,887 | |
Quantum Cyber N.V. (QUCY)
Quantum Cyber N.V. (QUCY)